Author:
Qian Zheng-Yu,Duan Chong-Yang,Cao Pei-Hua,Li Xue-Xin,Cai Zeng-Zhi,Li Ji-Bin,Chen Ping-Yan,Xu Rui-Hua,Wang Zi-Xian
Funder
National Natural Science Foundation of China
Chinese Academy of Sciences
Sun Yat-Sen University
Reference25 articles.
1. Profiling of immune features to predict immunotherapy efficacy;Ye;Innovation,2022
2. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke;Sacks;Int J Stroke,2018
3. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018
4. Advancing to the era of cancer immunotherapy;Wang;Cancer Commun,2021
5. Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials;Wang;J Immunother Cancer,2021